PGT-SR (preimplantation genetic testing for structural rearrangements) is a test developed for carriers of chromosome rearrangements
Chromosome rearrangements are formed when one or more pieces of chromosomes, the structures that contain an individual’s genetic material, find themselves in an altered position. For example, one common type of rearrangement, called a ‘translocation’, occurs when there is an exchange of materials between two chromosomes.
Approximately 1 in 500 people carry a chromosome rearrangement. People who have a balanced chromosome rearrangement in their cells are usually healthy, but they are at increased risk of producing pregnancies where the fetus has pieces of chromosome lost or duplicated. This loss or duplication of parts of a chromosome often leads to miscarriage, or the birth of children with disabilities.
PGTseq-SR (preimplantation genetic testing for structural rearrangements) is a test developed for carriers of chromosome rearrangements, which examines embryos produced using IVF technology in an attempt to distinguish embryos that are normal or balanced for the structural rearrangement from those that have pieces of chromosome missing or duplicated. Only embryos predicted to be normal/balanced are transferred to the uterus and consequently the risks of a miscarriage or abnormal pregnancy are reduced.
Insertion is when a fragment of a chromosome is detached from its original place and inserted into another chromosome.
When two breaks occur on the same chromosome, and the resulting fragment rotates before inserting back into the chromosome, this leads to ‘inversions’. When eggs or sperm are produced, the normal and inverted copies of the chromosome come together and exchange pieces. The presence of the inversion can result in a proportion of the gametes to lose parts of the affected chromosome, while duplicating other areas.
Juno Genetics’ PGT-SR technology uses next-generation sequencing in order to provide the best possible accuracy rates (exceeding 95%). The highly-validated test assesses thousands of sites on each chromosome, measuring the amount of DNA at each point in order to calculate the number of chromosomes. In many cases, this analysis is supplemented by analyzing variations in the DNA sequence, known as single nucleotide polymorphisms (SNPs), further enhancing the accuracy of the test.
Case feasibility assessed by Juno
Biopsy and embryo vitrification
Sample sent to Juno Genetics
PGTseq-SR 7 working days
Transfer of normal embryos
A detailed description of the PGTseq-SR method and its requirements is given in the Juno Genetics User Manual. In brief, Juno can undertake a new PGTseq-SR case once a genetic report describing the chromosomal rearrangement has been received and a Juno scientist has confirmed that PGTseq-SR is technically possible. A completed Requisition Form, formally requesting PGTseq-SR and providing relevant information concerning the patients, is also required. Rarely, PGTseq-SR is not technically possible. For this reason, patients should not begin a cycle until Juno has reviewed the patient’s genetic report and confirmed that PGTseq-SR is feasible.